111 related articles for article (PubMed ID: 17977823)
1. Tumor necrosis factor alpha enhances nicotinic receptor up-regulation via a p38MAPK-dependent pathway.
Gahring LC; Osborne-Hereford AV; Vasquez-Opazo GA; Rogers SW
J Biol Chem; 2008 Jan; 283(2):693-9. PubMed ID: 17977823
[TBL] [Abstract][Full Text] [Related]
2. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
3. Choline promotes nicotinic receptor alpha4 + beta2 up-regulation.
Gahring LC; Vasquez-Opazo GA; Rogers SW
J Biol Chem; 2010 Jun; 285(26):19793-801. PubMed ID: 20392695
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of nicotinic acetylcholine receptor (nAChR) upregulation in the transfected cell line, M10.
Whiteaker P; Sharples CG; Wonnacott S
Biochem Soc Trans; 1997 Aug; 25(3):550S. PubMed ID: 9388764
[No Abstract] [Full Text] [Related]
5. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
6. Chronic ethanol treatment decreases [3H]epibatidine and [3H]nicotine binding and differentially regulates mRNA levels of nicotinic acetylcholine receptor subunits expressed in M10 and SH-SY5Y neuroblastoma cells.
Gorbounova O; Svensson AL; Jönsson P; Mousavi M; Miao H; Hellström-Lindahl E; Nordberg A
J Neurochem; 1998 Mar; 70(3):1134-42. PubMed ID: 9489734
[TBL] [Abstract][Full Text] [Related]
7. Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
Huang Y; Zhu Z; Xiao Y; Laruelle M
Bioorg Med Chem Lett; 2005 Oct; 15(19):4385-8. PubMed ID: 16039849
[TBL] [Abstract][Full Text] [Related]
8. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
9. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
[TBL] [Abstract][Full Text] [Related]
10. Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras.
Harkness PC; Millar NS
J Neurosci; 2002 Dec; 22(23):10172-81. PubMed ID: 12451118
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of cell-surface alpha4beta2 neuronal nicotinic receptors by lower temperature and expression of chimeric subunits.
Cooper ST; Harkness PC; Baker ER; Millar NS
J Biol Chem; 1999 Sep; 274(38):27145-52. PubMed ID: 10480930
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Nicotinic Acetylcholine Receptor alph4+beta2 through a Ligand-Independent PI3Kbeta Mechanism That Is Enhanced by TNFalpha and the Jak2/p38Mapk Pathways.
Rogers SW; Gahring LC
PLoS One; 2015; 10(11):e0143319. PubMed ID: 26619345
[TBL] [Abstract][Full Text] [Related]
13. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.
Deuther-Conrad W; Patt JT; Feuerbach D; Wegner F; Brust P; Steinbach J
Farmaco; 2004 Oct; 59(10):785-92. PubMed ID: 15474055
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
Gentry CL; Wilkins LH; Lukas RJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
[TBL] [Abstract][Full Text] [Related]
15. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells.
Warpman U; Friberg L; Gillespie A; Hellström-Lindahl E; Zhang X; Nordberg A
J Neurochem; 1998 May; 70(5):2028-37. PubMed ID: 9572289
[TBL] [Abstract][Full Text] [Related]
16. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
Xiao Y; Kellar KJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
[TBL] [Abstract][Full Text] [Related]
17. The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity.
Lansdell SJ; Millar NS
Neuropharmacology; 2000 Feb; 39(4):671-9. PubMed ID: 10728888
[TBL] [Abstract][Full Text] [Related]
18. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
Dávila-García MI; Musachio JL; Kellar KJ
J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
[TBL] [Abstract][Full Text] [Related]
19. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
[TBL] [Abstract][Full Text] [Related]
20. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism.
Eilers H; Schaeffer E; Bickler PE; Forsayeth JR
Mol Pharmacol; 1997 Dec; 52(6):1105-12. PubMed ID: 9415721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
